Press Releases Choose Year All Items 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 1982 Search Press Releases Found 83 Results June 17, 2021 Surrozen Presents Data Supporting Potential of SZN-043 at The Liver Biology Conference: Fundamental Mechanisms and Translational Applications June 1, 2021 Surrozen Publishes Article in Nature Communications Demonstrating Selective Wnt Mimetics Stimulate Bone Mass Accrual in Disease Models of Osteoporosis,Aging and Long-Bone Fracture May 24, 2021 Surrozen Presents Data from Lead Wnt-Modulating Antibody Programs, SZN-1326 and SZN-043,in Six Oral and Poster Presentations at 2021 Digestive Disease Week Conference May 6, 2021 Surrozen Strengthens Board of Directors with Appointments of Mace Rothenberg, M.D.,and Christopher Chai April 15, 2021 Surrozen and Consonance-HFW Acquisition Corp. Announce Business Combination, Creating Publicly Listed Leader in Wnt Biology and Tissue Regeneration March 11, 2021 Surrozen Expands Board of Directors with Appointment of Mary Haak-Frendscho,Ph.D. February 2, 2021 Surrozen Expands Board of Directors with Appointment of Shao-Lee Lin, M.D.,Ph.D. November 12, 2020 Surrozen to Present at the Stifel 2020 Virtual Healthcare Conference October 29, 2020 Surrozen Appoints Charles Williams as Chief Financial Officer October 15, 2020 Surrozen Awarded NIH Grant to Support Development of SZN-043, a Liver-Specific Regenerative Antibody,for the Treatment of Severe Alcoholic Hepatitis «...56789»
